Safety

Researchers make progress in vaccine for botulinum toxin

Emergency Management Alert, March 19, 2003

Researchers recently made advances toward developing an inhaled vaccine against botulinum toxin, the cause of the occasionally fatal disease botulism and a potential bioterrorism weapon, Reuters reports.

Besides its potential use by bioterrorists, botulinum toxin is better known for the use of a purified form of the toxin called Botox, which the Food and Drug Administration approved last year for the treatment of facial wrinkles. Even though the purified toxin can be safely used as a wrinkle smoother, botulinum toxin remains a deadly poison that attacks the nervous system and paralyzes muscles, including those needed to breathe.

Most cases of botulism occur when a person swallows something that contains the toxin. But researchers at Jefferson Medical College in Philadelphia found that botulinum toxin could be absorbed through the lungs. This led the team to a possible new approach to develop oral and inhaled vaccines, with funding from the National Institutes of Health and biotechnology firms. Such vaccines would make vaccination of large numbers of people much easier.

    Hospital Safety Center
  • Hospital Safety Center

    Improve compliance with hospital safety standards from The Joint Commission, OSHA, and other regulators with this...

  • Healthcare Life Safety Compliance

    Learn Life Safety Code tips and interpretations for healthcare facilities with this in-depth monthly resource.

  • Hospital Safety Connection

    Stay on top of hospital safety requirements and best practices with our free, fast-paced weekly update.

  • Administering Your OSHA Program

    This course will help an employee new to the role of OSHA safety officer. It gives an overview of OSHA requirements and...

  • Medical OSHA Manual Combo

    Get into compliance with Quality America's OSHA Safety Program Manual and stay in compliance with OSHA Watch Newsletter...

Most Popular

Related Articles